During the past decade, ProCare Vision Centers conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 20 clinical trials were completed, i.e. on average, 76.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 19 clinical trials were completed. i.e. 90.5% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "ProCare Vision Centers" #1 collaborator was "Alcon Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ProCare Vision Centers" are "Visual Acuity" (19 trials), "Myopia" (3 trials), "Presbyopia" (3 trials), "Contact Lens Complication" (1 trials) and "Dry Eye" (1 trials). Many other conditions were trialed in "ProCare Vision Centers" in a lesser frequency.

Most popular intervention types in "ProCare Vision Centers" are "Device" (26 trials). Other intervention types were less common.

The name of intervention was led by "Dailies Total 1® Multifocal Contact Lens" (3 trials), "Dailies Total 1® Multifocal Contact Lenses" (3 trials), "ACUVUE Oasys 1-Day" (2 trials), "JJV Investigational Multifocal Contact Lens" (2 trials) and "JJVC Investigational Multifocal Contact Lens" (2 trials). Other intervention names were less common.

The vast majority of trials in "ProCare Vision Centers" are 26 trials for "All" genders.

Currently, there are NaN active trials in "ProCare Vision Centers". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in ProCare Vision Centers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ProCare Vision Centers, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 26 trials that are defined as “Not Applicable".